Drug Type Antibody |
Synonyms Anti BMP-2/4 neutralizing Ab (Stem Cell Medicine) |
Target |
Mechanism BMP2 inhibitors(Bone morphogenetic protein 2 inhibitors), BMP4 inhibitors(Bone morphogenetic protein-4 ligand inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | IL | 30 Nov 2019 |